These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1657214)

  • 1. Characterization of protective viral glycoproteins for pseudorabies virus infection.
    Matsuda A; Okada N; Katayama S; Okabe T; Sasaki N
    J Vet Med Sci; 1991 Aug; 53(4):737-41. PubMed ID: 1657214
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection from pseudorabies virus challenge in mice by a combination of purified gII, gIII and gVI antigens.
    Matsuda Tsuchida A; Katayama S; Okada N; Okabe T; Sasaki N
    J Vet Med Sci; 1992 Jun; 54(3):447-52. PubMed ID: 1322712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of mice and swine from pseudorabies virus-induced mortality by administration of pseudorabies virus-specific mouse monoclonal antibodies.
    Marchioli C; Yancey RJ; Timmins JG; Post LE; Young BR; Povendo DA
    Am J Vet Res; 1988 Jun; 49(6):860-4. PubMed ID: 2840843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing antibody titres in pig serum after revaccination with an inactivated Aujeszky disease virus (ADV) vaccine.
    Jakubik J; Wittmann G
    Zentralbl Veterinarmed B; 1978 Nov; 25(9):741-51. PubMed ID: 217206
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of antibodies to pseudorabies virus by immunization with antiidiotypic antibodies.
    Gurish MF; Ben-Porat T; Nisonoff A
    Ann Inst Pasteur Immunol; 1988; 139(6):677-87. PubMed ID: 2849957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of protective immunity and neutralizing antibodies to pseudorabies virus by immunization of anti-idiotypic antibodies.
    Tsuda T; Onodera T; Sugimura T; Murakami Y
    Arch Virol; 1992; 124(3-4):291-300. PubMed ID: 1318708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biology of pseudorabies (Aujeszky's disease) virus.
    Mettenleiter TC
    Comp Immunol Microbiol Infect Dis; 1991; 14(2):151-63. PubMed ID: 1657509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping and characterization of neutralizing epitopes of glycoproteins gIII and gp50 of the Indiana-Funkhauser strain of pseudorabies virus.
    Coe NE; Mengeling WL
    Arch Virol; 1990; 110(1-2):137-42. PubMed ID: 1689995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI.
    Ishii H; Kobayashi Y; Kuroki M; Kodama Y
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1411-4. PubMed ID: 2838579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
    Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
    Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of glycoprotein gC-rich antigen against pseudorabies virus.
    Katayama S; Okada N; Yoshiki K; Okabe T; Shimizu Y
    J Vet Med Sci; 1997 Aug; 59(8):657-63. PubMed ID: 9300361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay.
    van Oirschot JT; Rziha HJ; Moonen PJ; Pol JM; van Zaane D
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1179-82. PubMed ID: 3011974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of various non-oily adjuvants in immunization against the Aujeszky's disease (pseudorabies) virus.
    Puentes E; Cancio E; Eiras A; Nores MV; Aguilera A; Regueiro BJ; Seoane R
    Zentralbl Veterinarmed B; 1993 Jul; 40(5):353-65. PubMed ID: 8237208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA priming and killed virus boosting vaccination strategy can augment the immune response to pseudorabies virus.
    Chen ZH; Guo X; Ge XN; Jia H; Yang HC
    Acta Virol; 2007; 51(3):163-70. PubMed ID: 18076306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vector DNA vaccine encoding pseudorabies virus immediate early protein demonstrates partial protection in mice against lethal virus challenge.
    Chang SW; Bu J; Rompato G; Garmendia AE
    Viral Immunol; 1998; 11(1):27-36. PubMed ID: 9586695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inoculation of swine with inactivated Aujeszky vaccine: reduction of the inoculation dose, a cutaneous allergy test and the effect of vaccination on viremia].
    Jakubik J; Wittmann G
    Dtsch Tierarztl Wochenschr; 1979 Nov; 86(5):438-40. PubMed ID: 231509
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological characteristics of Aujeszky's disease virus glycoprotein].
    Vrublevskaia VV; Musienko VS; Skarga IuIu; Morenkov OS
    Vopr Virusol; 2007; 52(3):33-7. PubMed ID: 17601050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs.
    Yuan Z; Zhang S; Liu Y; Zhang F; Fooks AR; Li Q; Hu R
    Vaccine; 2008 Mar; 26(10):1314-21. PubMed ID: 18262313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of immune responses to glycoprotein gD of Aujeszky's disease virus with DNA immunization.
    Hwang DY; Lee JB; Kim TJ; Song JY; Hyun BH; Song CS; Park SY
    J Vet Med Sci; 2001 Jun; 63(6):659-62. PubMed ID: 11459012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinction between Aujeszky's disease virus-infected and vaccinated pigs by hemagglutination-inhibition test.
    Shibata I; Uruno K; Samegai Y; Inaba Y
    J Vet Med Sci; 1993 Oct; 55(5):859-61. PubMed ID: 8286546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.